Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wiman

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
The Biochemical Journal|October 1, 1980
Affinity-chromatographic purification of human alpha 2-antiplasminB Wiman
Current Opinion in Hematology|September 1, 1996
Plasminogen activator inhibitor 1 in thrombotic diseaseB Wiman
Thrombosis and Haemostasis|July 1, 1995
Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic diseaseB Wiman
European Journal of Biochemistry|June 1, 1977
Primary structure of the B-chain of human plasminB Wiman
European Journal of Biochemistry|November 1, 1973
Primary structure of peptides released during activation of human plasminogen by urokinaseB Wiman
Thrombosis Research|February 24, 2001
Discovery of PAI-1 in plasmaB Wiman
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 2, 1999
Predictive value of fibrinolytic factors in coronary heart diseaseB Wiman
Hematology/Oncology Clinics of North America|May 12, 2000
The fibrinolytic enzyme system. Basic principles and links to venous and arterial thrombosisB Wiman
Acta Medica Scandinavica. Supplementum|January 1, 1987
The role of the fibrinolytic system in thrombotic diseaseB Wiman
Thrombosis Research|January 1, 1980
On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or alpha 2-antiplasminB Wiman
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
The Biochemical Journal|October 1, 1980
Affinity-chromatographic purification of human alpha 2-antiplasminB Wiman
Current Opinion in Hematology|September 1, 1996
Plasminogen activator inhibitor 1 in thrombotic diseaseB Wiman
Thrombosis and Haemostasis|July 1, 1995
Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic diseaseB Wiman
European Journal of Biochemistry|June 1, 1977
Primary structure of the B-chain of human plasminB Wiman
European Journal of Biochemistry|November 1, 1973
Primary structure of peptides released during activation of human plasminogen by urokinaseB Wiman
Thrombosis Research|February 24, 2001
Discovery of PAI-1 in plasmaB Wiman
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 2, 1999
Predictive value of fibrinolytic factors in coronary heart diseaseB Wiman
Hematology/Oncology Clinics of North America|May 12, 2000
The fibrinolytic enzyme system. Basic principles and links to venous and arterial thrombosisB Wiman
Acta Medica Scandinavica. Supplementum|January 1, 1987
The role of the fibrinolytic system in thrombotic diseaseB Wiman
Thrombosis Research|January 1, 1980
On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or alpha 2-antiplasminB Wiman
Pageof 13